Dr Mark Marshall

BHB MBChB MPH (Hons) Auck


Mark initially trained as a nephrologist in New Zealand, but furthered his training in the United States in the late 1990s. He has been a consultant nephrologist at Middlemore Hospital in Auckland, New Zealand for approximately 20 years, and an adjunct academic at the University of Auckland for about half that time. He was Chair of the New Zealand professional and governmental governance groups for nephrology from 2009 to 2014. Since that time, he has taken on the role of Director of Medical Affairs (Chronic Renal) for Baxter Healthcare International in the Asia Pacific Region. He has published numerous articles and book chapters in the international literature. He lives in Helensville, New Zealand. 

Research | Current

  • Management of acute kidney injury in critical illness
  • Technical and clinical aspects of renal dialysis
  • Epidemiology and clinical trials in dialysis medicine
  • Biomedical devices for renal replacement therapy
  • Health service delivery in marginalized and elderly populations

Postgraduate supervision

Primary and co-supervision of Master and PhD students.

Selected publications and creative works (Research Outputs)

  • Marshall, M. R., & Karaboyas, A. (2020). Temporal changes in dialysate [Na+] prescription from 1996 to 2018 and their clinical significance as judged from a meta-regression of clinical trials. Seminars in dialysis, 33 (5), 372-381. 10.1111/sdi.12906
  • Wei, T., Chen, Z., Li, P., Tang, X., Marshall, M. R., Zhang, L., & Fu, P. (2020). Early use of endotoxin absorption by oXiris in abdominal septic shock: A case report. Medicine, 99 (28)10.1097/md.0000000000019632
  • Marshall, M. R. (2020). The benefit of early survival on PD versus HD-Why this is (still) very important. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 40 (4), 405-418. 10.1177/0896860819895177
  • Goossen, K., Becker, M., Marshall, M. R., Bühn S, Breuing, J., Firanek, C. A., ... Yao, Q. (2020). Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials. American journal of kidney diseases : the official journal of the National Kidney Foundation, 75 (6), 830-846. 10.1053/j.ajkd.2019.10.004
  • Wang, A. Y.-M., Zhao, J., Bieber, B., Kanjanabuch, T., Wilkie, M., Marshall, M. R., ... PDOPPS Dialysis Prescription and Fluid Management Working Group (2020). International comparison of peritoneal dialysis prescriptions from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 40 (3), 310-319. 10.1177/0896860819895356
  • Chan, S., Marshall, M. R., Ellis, R. J., Ranganathan, D., Hawley, C. M., Johnson, D. W., & Wolley, M. J. (2020). Haemodialysis withdrawal in Australia and New Zealand: a binational registry study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 35 (4), 669-676. 10.1093/ndt/gfz160
  • Marshall, M. R., Vandal, A. C., de Zoysa, J. R., Gabriel, R. S., Haloob, I. A., Hood, C. J., ... Rabindranath, K. S. (2020). Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial. Journal of the American Society of Nephrology : JASN10.1681/asn.2019090877
    Other University of Auckland co-authors: Alain Vandal
  • Wolley, M. J., Hawley, C. M., Johnson, D. W., Marshall, M. R., & Roberts, M. A. (2019). Incremental and twice weekly haemodialysis in Australia and New Zealand. Nephrology (Carlton, Vic.), 24 (11), 1172-1178. 10.1111/nep.13556


Contact details

Alternative contact


+64 21 393037

Primary office location

Level G, Room G01
New Zealand

Web links